Vertex is expanding R&D operations — in San Diego.
The big biotech company formally cut the ribbon today on a bigger facility that extends their footprint in the region to 170,000 square feet.
The new R&D site is largely devoted to work on new cystic fibrosis drugs, where Vertex has been making rapid progress with some next-gen therapies. There’s also a 4,000-square-foot incubator to work with new partners in San Diego, one of three research centers Vertex identified when it steered the research group into a reorganization a little more than a year ago.
Vertex decided to shutter its Canadian operations early last year, laying off around 70 staffers as it concentrated its research work at three main spots, which includes its Boston HQ, Milton Park, and London. According to an SEC filing at the time, some weaker than expected revenue numbers forced their hand, with execs trimming some HQ positions as well.
The expansion in San Diego was completed in 18 months.
Image: Vertex building, San Diego. Vertex
(CORRECTION: An earlier version of this story said Vertex planned on new hires for the expanded facility. That is incorrect. Endpoints News regrets the error.)
The best place to read Endpoints News? In your inbox.
Comprehensive daily news report for those who discover, develop, and market drugs. Join 31,500+ biopharma pros who read Endpoints News by email every day.Free Subscription